Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 17, 2022
Emery Pharma has expanded its lab. The extension of its new laboratory is streamlined to support research and development of large molecule drugs including, biologics, antibody-drug conjugates, biosimilars and others.
read more
Friday, September 08, 2023
Eminence Biotechnology (Suzhou) Co., Ltd. announced that its state-of-the-art facility for the commercial production of cell culture media is now fully operational.
read more
Wednesday, February 06, 2019
EMMAC announced that Malta Enterprise has granted EMMAC a Letter of Intent under terms of the Production of Cannabis for Medicinal Use Act, 2018, Chapter 578 of the Laws of Malta.
read more
The agreement makes Endari available to patients represented by the Department of Defense, which include three million active military personnel and 9.4 million beneficiaries.
read more
Wednesday, September 19, 2018
Emmaus Life Sciences has entered into a distribution agreement with Cardinal Health.
read more
Emmaus Life Sciences has entered into a distribution agreement with McKesson Plasma and Biologics.
read more
Emmes has acquired Casimir, a U.S.-based CRO. Casimir has experience in more than 20 rare diseases and has worked with regulators, sponsors and patients to develop outcome measures that capture the nuances of disease progression and treatment benefit...
read more
Wednesday, January 05, 2022
Emmes, a global, full-service Clinical Research Organization (CRO) announced that it has acquired Institut Dr. Schauerte, a CRO headquartered in Munich, Germany. Founded in 1990, Institut Dr. Schauerte is a full-service, technology-oriented CRO that ...
read more
Wednesday, November 17, 2021
Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced a partnership with MedGenome aimed at accelerating breakthrough treatments, powered by ...
read more
Emmes announced that it provided the data and statistical analysis support for the Phase 1 clinical trial of the investigational COVID-19 vaccine mRNA-1273.
read more
Monday, February 08, 2021
Emmes announced progress in its role as Data Coordinating Center for studies conducted under the Best Pharmaceuticals for Children Act (BPCA).
read more
Wednesday, September 20, 2023
Emmes, a global, full-service Clinical Research Organization (CRO) announced that Peter Ronco has been named Chief Executive Officer.
read more
Emmes announced that Kathleen Wolf has joined the company as vice president of clinical operations.
read more
Thursday, September 05, 2024
Emmes has been selected by the National Institutes of Health's (NIH) NIDA [National Institute of Drug Abuse] to support their Clinical Trials Network (CTN) for a multi-task, IDIQ contract.
read more
Emmes announced the award of eight new task order contract awards associated with the Helping to End Addiction Long-term Initiative, known as the NIH HEAL Initiative.
read more